What does future of internal medicine look like?

The first response is spot on. Not sure the np really is one. Our pipline for IM sucks. The future at Pfizer is in oncology or specialty. Use your I M experience to springboard out to one of those.

It’s ridiculous how we are expected to see 10 HCP ‘s a day, use all our materials and buy lunch about every day. If I were to buy that many lunches I would be so far out of compliance on the once a month limitation the lawyers would be calling. Then to top it off there’s ar 5 of us “ selling” cologuard to the same doctors. 4 of us selling Chantix. Two on Eucrisa the good drug no one wants because of the prior auth.

Sounds like at least three of you should be gone.
 




No, this is exactly why it IS sales. If left to all the background forces a primary care physician would seldom if ever choose a brand over a generic. A good rep is able to convince and persuade a provider to “fight the system” based on the merits of the product and by leveraging their relationship, which includes trust. And by the way if you are going in promoting a broad formulary message like “all your UHC patients can get product x” then you are not credible; there are almost always carve out and exceptions; again if you have sold the provider they have in their mind resolved that the benefits outweigh the potential hassle factor in prescribing.

In my neck of the woods (NE) almost all the practices are owned by hospital systems that shut off access. My primary care doc who used to be very rep friendly is now owned by a hospital and he no longer sees reps. We talk about how things have changed whenever I see him. Bottom line-hard to sell to someone you don't see....even if you are the greatest rep in the world. When (not if) Medicare starts negotiating the party is really over for reps.
 




You are describing a very “average” rep who’s ideal of a “good year” is being in the top half. Not all people in sales are salespeople, regardless of the industry. Pharma just tolerates mediocrity more than most industries.

More accurately, Pfizer itself, personifies/ defines mediocrity. Pfizer would be long gone without all the acquisitions/ takeovers. R&D has never produced any drug with any real significance. Most reps are obnoxious, clueless dupes. Management is populated by the same promoted from the ranks.....l
 




More accurately, Pfizer itself, personifies/ defines mediocrity. Pfizer would be long gone without all the acquisitions/ takeovers. R&D has never produced any drug with any real significance. Most reps are obnoxious, clueless dupes. Management is populated by the same promoted from the ranks.....l

Educate yourself.
 




More accurately, Pfizer itself, personifies/ defines mediocrity. Pfizer would be long gone without all the acquisitions/ takeovers. R&D has never produced any drug with any real significance. Most reps are obnoxious, clueless dupes. Management is populated by the same promoted from the ranks.....l

True. PFE even bought Lipitor or should I say Warner Lambert to get it.
 
























You know management is concerned when they have us making endless advocates lists, issuing a focused target list for every product made by those who have no idea that half of the providers on there are no see. They are trying to measure everything to justify their position and the existence of their division.
The T3 regions are ridiculous in size. The rankings are so skewed Because of the disparity of plans, coverages, state formularies etc. Pfizer could take a que from Merck and streamline the operation. One rep on a product in a territory.
Truly modernize the job. Measure “ stops”. Get honest activity reports from the office interactions. Checklist Leave behinds and the ability to record staff interactions. There are hardly any samples left to leave so how do you account for a full day working?
Update the VCC by making it a click through from a social media link, or direct contact with the assigned territory rep. Face it, the job is changing time for an overhaul.
 




You know management is concerned when they have us making endless advocates lists, issuing a focused target list for every product made by those who have no idea that half of the providers on there are no see. They are trying to measure everything to justify their position and the existence of their division.
The T3 regions are ridiculous in size. The rankings are so skewed Because of the disparity of plans, coverages, state formularies etc. Pfizer could take a que from Merck and streamline the operation. One rep on a product in a territory.
Truly modernize the job. Measure “ stops”. Get honest activity reports from the office interactions. Checklist Leave behinds and the ability to record staff interactions. There are hardly any samples left to leave so how do you account for a full day working?
Update the VCC by making it a click through from a social media link, or direct contact with the assigned territory rep. Face it, the job is changing time for an overhaul.

In short, its over.
 




Simple answer:

When the dolts in charge of the PC division( I can't keep up with the ever constant nomenclature changes) get rid of the USELESS POAs, they will likely have evolved to see that our primary care division is a vestigial organ and cut it out or reduce numbers drastically. Hopefully starting in NYC.
 












We have an exciting POA coming up. Everyone should be happy, it should bring #joy. We get to strategize with our teams and figure out how to make breakthroughs that change patient's lives. Hope everyone has a great meeting!
 
















We have an exciting POA coming up. Everyone should be happy, it should bring #joy. We get to strategize with our teams and figure out how to make breakthroughs that change patient's lives. Hope everyone has a great meeting!

Hahahaha! Best joke I’ve heard in a long time.
POA’s are mind fucks w/o lubrication.